Company intelligence / Profile preview

Respira Therapeutic Massage

Albuquerque, New Mexico, United Statesrespirabodywork.massageplanet.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Respira Therapeutics has completed a Phase 2b clinical trial of RT234, an inhaled vardenafil powder delivered via its proprietary AOS™ DPI device, showing acute improvement in exercise capacity and reduction of dyspnea in PAH patients; results were presented at ATS International Conference May 2025[7].

Therapeutic areas: Cardiovascular
Modalities: Small moleculeDevice
Industry: Biotech

Beyond the preview

Go deeper on Respira Therapeutic Massage.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respira Therapeutic Massage.

Explore the full profile